Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

The Motley Fool July 6, 2004 Brian Gorman	3M's Pharma Push 3M's Aldara may draw the firm into the drug manufacturers' blockbuster trap.
The Motley Fool July 24, 2009 David Lee Smith	3M Keeps Posting Profits With some companies disappointing, the Post-It maker turns in a solid quarter.
The Motley Fool October 23, 2007 David Lee Smith	3M: Punished for Performance Despite rolling out record third-quarter sales and earnings, the company watched its shares tumble amid an increasingly cautious look ahead.
The Motley Fool April 19, 2004 W.D. Crotty	3M: Money, Margins, Magnificent Trusty old 3M is no ordinary industrial conglomerate.
The Motley Fool June 21, 2011 Brian Orelli	Data Look Good, Approval Unknown Accelerated approvals are like that. The data should give Curis' investors added confidence that vismodegib works, but whether it can get approved with this limited data remains to be seen.
The Motley Fool July 25, 2006 Alyce Lomax	Investors Whack 3M Old news is bad news for 3M. It doesn't make too much sense to see even more weakness in a stock on the same negative news investors already expected.
The Motley Fool October 22, 2008 David Lee Smith	3M Sticks to Your Portfolio Despite a sluggish economy, 3M managed across-the-board improvement.
The Motley Fool July 30, 2007 Ryan Fuhrmann	3M Bucks the Trend Given its track record, it's hard to argue against 3M, and judging by a recently cranky Mr. Market, more investors may be heading into 3M's stable arms.
The Motley Fool March 21, 2011 Brian Orelli	Let's See Some Data, Curis Curis investors seem to have shrugged off the multiple unknowns and embraced the potential for the company's skin cancer drug.
The Motley Fool August 4, 2005 Jack Uldrich	3M: Great at the Little Things The maker of Scotch Tape, Post-It Notes, and Thinsulate is also a nanotech powerhouse well-positioned to employ the emerging science of the small across its entire line of diversified products. Investors, take note.
The Motley Fool March 16, 2004 Rick Aristotle Munarriz	3M Makes More Money 3M boosts its 2004 outlook again. It's an adhesive charm.
The Motley Fool January 26, 2011 David Lee Smith	3M's Tiny Beat Hurts Its Shares While it topped the analysts' forecast, the market found 3M's results less than inspiring.
The Motley Fool April 18, 2005 Stephen D. Simpson	3M Rolls On Some analysts may get hung up on a revenue shortfall, but results from the first quarter were good.
The Motley Fool April 27, 2007 Ryan Fuhrmann	3 Cheers for 3M Recent share price gains at diversified industrial and technology giant 3M may be due as much to a happy Mr. Market as to strong first-quarter results, but investors aren't complaining.
The Motley Fool January 24, 2006 Stephen D. Simpson	3M Needs to Get MMMoving New CEO George Buckley seems a bit more interested in engineering and innovation than his predecessor. Should he succeed in leveraging 3M's great base of engineering talent, better future growth is attainable. Investors, take note.
The Motley Fool April 28, 2009 David Lee Smith	Grey Skies to Clear Up at 3M? Stephen Roell, 3M's chief executive, displays some new optimism about the second half of this year.
IndustryWeek November 1, 2001 William H. Miller	New Leader, New Era Jim McNerney, passed over for GE's top job, sets 3M on a growth course...
BusinessWeek April 12, 2004 Michael Arndt	Why 3M Feels Right At Home In China Today, 3M is selling goods worth nearly $500 million annually in China, from industrial gear and components for consumer electronics to respiratory masks and the latest in Post-it Notes.
The Motley Fool November 9, 2004 Lawrence Meyers	3M Looks Mmm-Mmm Good It's easy to overlook this stalwart, but doing so means missing out on a solid investment. Its stock price has doubled over the past five years and quadrupled over the past 15 years.
The Motley Fool January 30, 2008 David Lee Smith	3M's Getting It Done Worldwide 3M is among a small group of companies doing well domestically and internationally. Investors, take note.
The Motley Fool May 11, 2005 Brian Gorman	3M's Global Focus 3M's emphasis on developing countries poses new opportunities and risks. 3M's investors should understand that future growth may be on shakier ground.
The Motley Fool March 23, 2007 Rick Aristotle Munarriz	3M Plays Catch-Up Despite volatility, the industrial conglomerate could still be a good long-term option.
The Motley Fool October 18, 2005 Stephen D. Simpson	3 Cheers for 3M? Sales and margin improvements underlie the value for investors here.
The Motley Fool September 14, 2010 Travis Hoium	3M Goes Shopping for Growth 3M has started buying again, but beware, the cost is high, and past acquisitions haven't made a big impact.
The Motley Fool February 16, 2010 Brian Orelli	For Blockbuster Cancer Drugs, Approvals Are the Easy Part Don't get too excited. As an investor, you can lower your risk by investing in cancer drug companies after a clinical trial success but before an FDA approval, but you'll also reduce your reward.
IndustryWeek January 1, 2004 John S. McClenahen	New World Leader 3M Co.'s James McNerney, CEO of the Year, is committed to operating excellence and organic growth through innovation, international strength, leadership development and Six Sigma.
The Motley Fool October 27, 2011 Eric Bleeker	Here's Where 3M's Finding Its Growth Where's your company generating its sales? Here's a look at where 3M's sales and earnings come from and how its sales abroad have changed over time.
The Motley Fool October 26, 2011 David Lee Smith	3M Joins a Wacky, Wild, and Wooly Earnings Season Tangled European economies and an LCD TV slowdown aren't helping 3M.
The Motley Fool September 15, 2008 David Lee Smith	3M May Mean "Make More Money" The St. Paul, Minnesota-based company sells products in many different areas from post-it notes to orthodontic products; its core businesses are strong and getting stronger.
The Motley Fool April 5, 2006 David Compton	3M's Pharma Unit for Sale The branded-drugs unit is on the block, and Wall Street likes the move. It allows 3M to focus on its core strengths, and the branded drugs will be much better marketed by a large pharmaceutical company.
The Motley Fool April 27, 2011 David Lee Smith	3M = Miraculous Money Maker 3M hits on all sectors and geographic areas while posting yet another solid quarter.
The Motley Fool February 23, 2011 Brian Richards	Here's Where 3M Makes Money A look at where the company is selling its goods.
The Motley Fool January 30, 2009 David Lee Smith	3M's Shares Rise Amid Sinking Earnings With its earnings down 37%, 3M tacked on 2% in a forlorn market.
The Motley Fool May 12, 2005 Brian Gorman	Drinking In 3M's CUNO Purchase The conglomerate gets more than just a niche business with the water filter company. Investors, take note.
The Motley Fool July 18, 2005 Stephen D. Simpson	3M's 3 Challenges Despite at least three significant challenges, 3M looks like a solid value. While the P/E seems a bit elevated, quality large-cap stocks usually do get a bit of a premium.
The Motley Fool April 25, 2008 David Lee Smith	3M's Downside-Up Quarter Take away year-ago asset sales, and 3M has grown earnings nicely.
The Motley Fool June 9, 2005 Seth Jayson	Value at Fair Value? Does holding out for the ultra-cheap hold us back? A 16% drop isn't normally enough to get my value sensors buzzing. But in the case of 3M, maybe a small discount should be enough to pique one's interest.
American Family Physician October 15, 2004 Stulberg, Crandell & Fawcett	Diagnosis and Treatment of Basal Cell and Squamous Cell Carcinomas Rates of squamous cell and basal cell carcinomas have been increasing. Primary care physicians can expect to diagnose six to seven cases of basal cell carcinoma and one to two cases of squamous cell carcinoma each year.
The Motley Fool July 19, 2005 Nick Baker	Fool by Numbers: 3M Q2 2005 3M posted second quarter results: Income Statement Highlights... Balance Sheet Highlights... Margin Checkup... Cash Flow Highlights...
The Motley Fool October 23, 2006 Seth Jayson	3M Steering Straight Solid earnings and straight talk make this a stock worth owning.
The Motley Fool October 19, 2005 Stephen D. Simpson	Tooling Around Illinois Tool Works The valuation outlook on this diversified manufacturing company is mixed.
The Motley Fool January 25, 2007 Chuck Saletta	Buy Cheap Growth The less you pay for growth, the more you'll likely be rewarded for it.
Information Today February 6, 2014	3M Cloud Library Launches in Canada and Debuts Automation Tool 3M announced that the 3M Cloud Library ebook lending system from 3M Library Systems is now available in Canada.
The Motley Fool January 23, 2006 Rich Smith	Foolish Forecast: Does 3M Spell Bingo? With 3M's projected earnings growth of 12% per annum over the next five years, you'd probably want its P/E of 19 and price-to-free cash flow ratio 17 to drop a bit before buying this one.
BusinessWeek April 12, 2004 Michael Arndt	3M's Rising Star Jim McNerney is racking up quite a record at 3M. Now, can he rev up its innovation machine?
The Motley Fool April 21, 2006 Stephen D. Simpson	MMM'mmm Good Like other conglomerates, 3M is coupling decent upper-single-digit revenue growth with margin improvements and driving nice double-digit earnings growth. Investors, take note.
The Motley Fool December 3, 2008 Rich Smith	This Just In: Upgrades and Downgrades Citi seems to think 3M is especially vulnerable to current trends and downgrades the stock to "sell."
BusinessWeek January 12, 2004	James McNerney No matter that the manufacturing sector was on the skids before he even showed up at 3M. The conglomerate has been flying since McNerney rolled out his five-part productivity overhaul in 2001.
The Motley Fool October 6, 2010 Rich Duprey	3M Retires From Insuring Its Retirees Company will change its retirement relationship with employees.
The Motley Fool July 19, 2004 Roger Nusbaum	3M Strong Despite Stock's Slip Experienced leadership keeps 3M, maker of Post-It Notes and Thinsulate, performing well.